Keytruda 100mg Injection

Keytruda 100mg Injection – Immunotherapy for Cancer Treatment

Keytruda 100mg Injection contains pembrolizumab, an immunotherapy used to treat certain types of cancer, including melanoma, non-small cell lung cancer, and more. Pembrolizumab is a monoclonal antibody that targets the PD-1 receptor, helping the immune system recognize and attack cancer cells more effectively.

Uses:

• Melanoma: Treatment for advanced melanoma in adults.
• Non-Small Cell Lung Cancer (NSCLC): Indicated for certain cases of advanced NSCLC, often in combination with other treatments.
• Other Cancers: Used in various cancers like head and neck squamous cell carcinoma, classical Hodgkin lymphoma, and more, as recommended by a healthcare provider.

How Keytruda 100mg Injection Works:

Pembrolizumab binds to the PD-1 receptor on immune cells, blocking cancer cells from evading immune detection. By targeting this receptor, Keytruda enables the immune system to identify and destroy cancer cells more effectively.

Common Side Effects:

• Fatigue
• Nausea
• Constipation or diarrhea
• Decreased appetite
• Joint pain

Serious Side Effects (Seek Immediate Medical Attention):

• Immune-related adverse reactions: Includes inflammation of the lungs (pneumonitis), liver (hepatitis), intestines (colitis), or kidneys (nephritis).
• Severe skin reactions: Such as blisters or peeling.
• Endocrine issues: Changes in thyroid or adrenal gland function.

Key Features:

• Contains pembrolizumab, an immune checkpoint inhibitor.
• Enhances immune response to target and destroy cancer cells.
• Effective in treating multiple cancer types, often in advanced stages.
• Administered as an intravenous infusion under medical supervision.

Precautions:

• Pregnancy Warning: Not recommended during pregnancy due to potential harm to the fetus.
• Immune-related reactions: Patients should report any unusual symptoms, as immune-related side effects may occur.
• Regular Monitoring: Necessary to assess liver function, thyroid function, and other organ systems.

Frequently Asked Questions (FAQ):

1. What is Keytruda 100mg Injection used for?
   Keytruda treats various cancers, including melanoma and NSCLC, by enhancing the immune system’s ability to attack cancer cells.
2. How is Keytruda administered?
   It is given as an intravenous infusion in a clinical setting, typically every 3 to 6 weeks, depending on the treatment plan.
3. Is Keytruda safe for pregnant women?
   No, Keytruda may harm the fetus and is not recommended during pregnancy.
4. Can Keytruda cause immune-related side effects?
   Yes, it can lead to immune-related adverse reactions affecting organs like the lungs, liver, and thyroid, which require prompt medical attention.
5. What should I do if I experience side effects?
   Report any unusual symptoms to your healthcare provider. Serious side effects may need immediate medical attention.

References:

1. Merck & Co., Inc. – Keytruda (Pembrolizumab) Product Information
   Available from: https://www.keytruda.com
   Accessed on: November 10, 2024.
2. European Medicines Agency – Pembrolizumab Information
   Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/keytruda
   Accessed on: November 10, 2024.
3. U.S. Food & Drug Administration – Keytruda (Pembrolizumab)
   Available from: https://www.fda.gov/drugs/keytruda
   Accessed on: November 10, 2024.